Driehaus Capital Management LLC Purchases New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Driehaus Capital Management LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,152 shares of the medical equipment provider’s stock, valued at approximately $601,000.

A number of other institutional investors have also recently bought and sold shares of the business. Atala Financial Inc purchased a new stake in Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $26,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Hurley Capital LLC bought a new position in Intuitive Surgical during the fourth quarter valued at $28,000. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on ISRG shares. Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Royal Bank of Canada reduced their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Finally, Bernstein Bank lifted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Insider Buying and Selling

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. This represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock worth $17,229,143 in the last quarter. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $536.55 on Friday. Intuitive Surgical, Inc. has a one year low of $379.67 and a one year high of $616.00. The firm has a market capitalization of $192.31 billion, a price-to-earnings ratio of 83.71, a PEG ratio of 5.85 and a beta of 1.70. The company’s fifty day moving average price is $500.93 and its 200-day moving average price is $534.86.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the business posted $1.50 earnings per share. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.